cancer risk with semaglutide What to know about new study showing weight loss drugs can lower A growing body of research

Hormonal Imbalances

Platforms that offer access to FDA-approved branded medications alongside compounded options may present a different risk profile than platforms offering compounded medications exclusively

He we show the results of an intervention to identify, at general practice level, which high-risk patients are overdue tests, with a view to facilitating targeted follow-up of those at greatest risk

While tweaking your habits can modestly increase your GLP-1, this small boost likely wont result in massive weight loss

Obesity is a chronic disease, and for many patients, ongoing medication is appropriate management, the same way someone with hypertension stays on blood pressure medication indefinitely

The other area of value is proactive care, or precision medicine